Covered recipient · General Payments record
SAMUEL C BORCHERDING
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$600.25
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $161.98 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| IDORSIA PHARMACEUTICALS US INC | $21.51 | 1 |
| DEXCOM, INC. | $21.24 | 1 |
| PFIZER INC. | $20.95 | 1 |
| Lilly USA, LLC | $19.88 | 1 |
| ABBVIE INC. | $16.74 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.46 | 1 |
| Novo Nordisk AS | $16.05 | 1 |
| Exact Sciences Corporation | $15.15 | 1 |
| Merck Sharp & Dohme Corporation | $14.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $16.74 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996283351 | CMS |
| Dexcom, Inc. | $21.24 | 08/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054734149 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.46 | 07/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015696229 | CMS |
| Exact Sciences Corporation | $15.15 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026705971 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $21.51 | 09/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034392593 | CMS |
| Lilly USA, LLC | $19.88 | 11/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032384267 | CMS |
| Merck Sharp & Dohme LLC | $14.00 | 10/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048835813 | CMS |
| Novo Nordisk Inc | $16.05 | 08/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002720719 | CMS |
| PFIZER INC. | $20.95 | 02/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050318111 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.